Leagh Erin Turner - 07 Nov 2023 Form 4 Insider Report for Ceridian HCM Holding Inc. (DAY)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
09 Nov 2023, 17:51:11 UTC
Prior SEC filing
11 Oct 2023
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ William E. McDonald, attorney-in-fact

Key filing fact

Leagh Erin Turner filed Form 4 for Ceridian HCM Holding Inc. (DAY) on 09 Nov 2023.

Key facts

  • This page summarizes Leagh Erin Turner's Form 4 filing for Ceridian HCM Holding Inc. (DAY).
  • 4 reported transactions and 10 derivative rows are listed below.
  • Accepted by SEC: 09 Nov 2023, 17:51.

Change

  • Previous filing in this sequence was filed on 11 Oct 2023.
  • Current net transaction value: -$114,225.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CDAY transaction

Common Stock

Options Exercise

Transaction value
$353,704
Shares
+7,084
Change %
+2.9%
Price
$49.93
Shares after
252,285
Date
07 Nov 2023
Ownership
Direct
Footnotes
F1
CDAY transaction

Common Stock

Sale

Transaction value
$296,193
Shares
-4,498
Change %
-1.8%
Price
$65.85
Shares after
247,787
Date
07 Nov 2023
Ownership
Direct
Footnotes
F1, F2
CDAY transaction

Common Stock

Sale

Transaction value
$171,736
Shares
-2,586
Change %
-1%
Price
$66.41
Shares after
245,201
Date
07 Nov 2023
Ownership
Direct
Footnotes
F1, F3, F4, F5

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CDAY transaction Derivative

Option (Right to Purchase)

Options Exercise

Transaction value
$0
Shares
-7,084
Change %
-100%
Price
$0.000000*
Shares after
0
Date
07 Nov 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
7,084
Exercise price
$49.93
Footnotes
F1, F6
CDAY holding Derivative

Option (Right to Purchase)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
187,321
Date
07 Nov 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
187,321
Exercise price
$65.26
Footnotes
F7
CDAY holding Derivative

Option (Right to Purchase)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
132,124
Date
07 Nov 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
132,124
Exercise price
$80.95
Footnotes
F8
CDAY holding Derivative

Performance Units

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
3,237
Date
07 Nov 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
3,237
Exercise price
Footnotes
F9
CDAY holding Derivative

Performance Units

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
16,182
Date
07 Nov 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
16,182
Exercise price
Footnotes
F10
CDAY holding Derivative

Performance Units

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
4,705
Date
07 Nov 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
4,705
Exercise price
Footnotes
F11
CDAY holding Derivative

Performance Units

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
52,922
Date
07 Nov 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
52,922
Exercise price
Footnotes
F12
CDAY holding Derivative

Performance Units

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
6,034
Date
07 Nov 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
6,034
Exercise price
Footnotes
F13
CDAY holding Derivative

Performance Units

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
68,558
Date
07 Nov 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
68,558
Exercise price
Footnotes
F14
CDAY holding Derivative

Performance Units

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
27,423
Date
07 Nov 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
27,423
Exercise price
Footnotes
F15
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 15 footnotes

Footnote F1

The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan, adopted by the Reporting Person on November 4, 2022.

Footnote F2

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.25 to $66.24 inclusive. The reporting person undertakes to provide Ceridian HCM Holding Inc., any security holder of Ceridian HCM Holding Inc. or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Footnote F3

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $66.25 to $66.62 inclusive. The reporting person undertakes to provide Ceridian HCM Holding Inc., any security holder of Ceridian HCM Holding Inc. or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Footnote F4

Includes, subject to forfeiture should the recipient fail to make an election to convert to shares prior to the ten year anniversary of the grant date, (i) of the 50,000 RSUs granted on September 4, 2018, 41,500 shares of Common Stock are issuable at the election of the recipient, (ii) 50,000 RSUs granted on September 9, 2019, that are issuable as shares of Common Stock at the election of the recipient, (iii) 1,538 RSUs granted on February 28, 2020, that are issuable as shares of Common Stock at the election of the recipient; and (iv) 20,073 RSUs granted on May 8, 2020, that are issuable as shares of Common Stock at the election of the recipient.

Footnote F5

Includes, subject to forfeiture should the recipient fail to make an election to convert to shares prior to the ten year anniversary of the grant date, (i) of the 63,532 RSUs granted on February 24, 2022, 21,177 shares of Common Stock are issuable at the election of the recipient, 21,177 RSUs vest and become issuable at the election of the recipient on February 24, 2024, and 21,178 RSUs vest and become issuable at the election of the recipient on February 24, 2025; and (ii) shares of Common Stock issuable pursuant to RSUs, granted on February 28, 2023, of which 22,852 RSUs vest and become issuable at the election of the recipient on February 28, 2024, and 22,853 RSUs vest and become issuable at the election of the recipient on each of February 28, 2025, and February 28, 2026.

Footnote F6

Fully vested and exercisable.

Footnote F7

Consists of 140,490 vested and exercisable options as of May 8, 2023, and 46,831 options that vest and become exercisable on May 8, 2024.

Footnote F8

Consists of 66,062 vested and exercisable options as of March 8, 2023, and 33,031 options that vest and become exercisable on each of March 8, 2024 and March 8, 2025.

Footnote F9

The vesting of 3,237 performance stock units ("PSUs") occurred on March 8, 2022, and the recipient has until March 8, 2031 to elect to convert any or all of the vested PSUs into shares of Common Stock.

Footnote F10

The vesting of 5,394 PSUs occurred on each of March 8, 2022 and March 8, 2023 respectively, and the recipient has until March 8, 2031 to elect to convert any or all of the vested PSUs into shares of Common Stock. The vesting of 5,394 PSUs occurs on March 8, 2024.

Footnote F11

Pursuant to the terms of the Company's 2022 Management Incentive Plan, the Company achieved a total payout of 83.3% under the performance metrics resulting in the vesting of 4,705 of the 5,648 PSUs granted on February 24, 2022. The vesting of the 4,705 PSUs occurred on February 24, 2023, and the recipient has until February 24, 2032 to elect to convert any or all of the vested PSUs into shares of Common Stock.

Footnote F12

Pursuant to the terms of the PSU award agreement, the Company achieved a total payout of 83.3% under the performance metrics, and each PSU converts into 0.833 shares of Common Stock upon vesting and issuance. As a result, 17,640 PSUs vested on February 24, 2023, and the recipient has until February 24, 2032 to elect to convert any or all of the vested PSUs into shares of Common Stock. The vesting of 17,641 PSUs occurs on each of February 24, 2024, and February 24, 2025.

Footnote F13

Each PSU represents a contingent right to receive shares of Common Stock based upon the degree to which one or more of the performance metrics under the Company's 2023 Management Incentive Plan ("2023 MIP") are satisfied. The number of PSUs reported in columns 5, 7 and 9 of Table II reflects achievement at the target level of performance under the 2023 MIP. Based on actual results during the fiscal year ended December 31, 2023, the aggregate number of shares of Common Stock issued may range from zero shares to 167% of the target number of shares reported in columns 5, 7, and 9 of Table II. The PSUs will only vest upon the later of (i) the date the Compensation Committee or the Board of Directors of the Company certify that one or more of the performance metrics have been met under the 2023 MIP for the individual and (ii) the one-year anniversary of the date of grant.

Footnote F14

Each PSU represents a contingent right to receive shares of Common Stock based upon the degree to which one or more of the performance metrics contained in the PSU award agreement ("PSU Agreement") are satisfied annually over a three year period. The number of PSUs reported in columns 5, 7, and 9 of Table II reflects achievement at the target level of performance under the PSU Agreement. Based on actual results during each of the preceding period beginning on January 1 and ending December 31, the aggregate number of shares of Common Stock issued may range from zero shares to 167% of the target number of shares reported in columns 5, 7 and 9 of Table II. The PSUs will only vest if the achievement of one or more of the annual performance metrics under the PSU Agreement is certified to have been met by the Compensation Committee or the Board of Directors of the Company for the prior period, and then any such certified amount will vest on the anniversary of the date of grant.

Footnote F15

Each PSU represents a contingent right to receive shares of Common Stock based upon the degree to which the performance metric contained in the PSU Agreement is satisfied. The number of PSUs reported in columns 5, 7, and 9 of Table II reflects achievement at the target level of performance under the PSU Agreement. Based on actual results during the period beginning January 1, 2023, and ending December 31, 2025, the aggregate number of shares of Common Stock issued may range from zero shares to 200% of the target number of shares reported in columns 5, 7 and 9 of Table II. The PSUs will only vest if the achievement of the performance metric under the PSU Agreement is certified to have been met by the Compensation Committee or the Board of Directors of the Company, and then any such certified amount will vest on February 28, 2026.

SEC remarks

For Leagh Turner pursuant to the Power of Attorney previously filed.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .